Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Food Effect on PK of ASP1517 in Healthy Men
NCT02805374Phase 1Completed
- Sponsor
- Astellas Pharma
- Start
- Jul 2016
- Primary completion
- Aug 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of roxadustat in anemia of chronic kidney disease (CKD-A) (2 arms), sponsored by Astellas Pharma. Primary endpoints: Area Under the Concentration-Time Curve from Time Zero to Infinity and Maximum Plasma Concentration. Started Jul 2016; status: completed.
02
Drugs
roxadustat
03
Conditions
anemia of chronic kidney disease (CKD-A)
Beyond the preview
Go deeper on NCT02805374.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02805374.